Skip to main content
NCBI home page
British Journal of Experimental Pathology logoLink to British Journal of Experimental Pathology
. 1983 Apr;64(2):166–171.

Prevention of carbon tetrachloride-induced liver necrosis by several amino acids.

E G De Toranzo, E C De Ferreyra, O M De Fenos, J A Castro
PMCID: PMC2040682  PMID: 6849812

Abstract

Aspartic acid, cystine, methionine and tyrosine were protective against carbon tetrachloride (CCl4)-induced liver necrosis 24 h after its administration, when given 30 min before the hepatotoxin. Aspartic acid, cystine and tyrosine were also effective when given as late as 6 h after CCl4. The protective effects of these amino acids, however, were no longer evident when observations of CCl4-induced necrosis were made at 72 h, except for cystine, which retained its protective potential. Protective amino acid administration did not modify the concentration of CCl4 in liver, nor did it decrease the intensity of the covalent binding of CCl4 reactive metabolites to cellular constituents or the CCl4-induced lipid peroxidation. Consequently, protection cannot be attributed to modulation of these parameters. Cystine, tyrosine and aspartic acid significantly lowered body temperature of the CCl4-treated rats, while methionine did not. Combined, these results suggest that the protective effect is not attributable to lowering of body temperature in CCl4-treated animals. Protection probably results from changes in the cell response to injury promoted by amino acid administration.

Full text

PDF
166

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Castro J. A., Cignoli E. V., De Castro C. R., De Fenos O. M. Prevention by cystamine of liver necrosis and early biochemical alterations induced by carbon tetrachloride. Biochem Pharmacol. 1972 Jan;21(1):49–57. doi: 10.1016/0006-2952(72)90249-3. [DOI] [PubMed] [Google Scholar]
  2. De Ferreyra E. C., Castro J. A., Díaz Gómez M. I., D'Acosta N., De Castro C. R., De Fenos O. M. Prevention and treatment of carbon tetrachloride hepatotoxicity by cysteine: studies about its mechanism. Toxicol Appl Pharmacol. 1974 Mar;27(3):558–568. doi: 10.1016/0041-008x(74)90035-0. [DOI] [PubMed] [Google Scholar]
  3. Ferreyra E. C., de Fenos O. M., Bernacchi A. S., de Castro C. R., Castro J. A. Treatment of carbon tetrachloride-induced liver necrosis with chemical compounds. Toxicol Appl Pharmacol. 1977 Dec;42(3):513–521. doi: 10.1016/s0041-008x(77)80036-7. [DOI] [PubMed] [Google Scholar]
  4. Klaassen C. D., Plaa G. L. Comparison of the biochemical alterations elicited in livers from rats treated with carbon tetrachloride, chloroform, 1,1,2-trichloroethane and 1,1,1-trichloroethane. Biochem Pharmacol. 1969 Aug;18(8):2019–2027. doi: 10.1016/0006-2952(69)90299-8. [DOI] [PubMed] [Google Scholar]
  5. LARSON R. E., PLAA G. L. A CORRELATION OF THE EFFECTS OF CERVICAL CORDOTOMY, HYPOTHERMIA AND CATECHOLAMINES ON CARBON TETRACHLORIDE-INDUCED HEPATIC NECROSIS. J Pharmacol Exp Ther. 1965 Jan;147:103–111. [PubMed] [Google Scholar]
  6. LARSON R. E., PLAA G. L. SPINAL CORD TRANSECTION AND CCL-4-TOXICITY. Experientia. 1963 Nov 15;19:604–606. doi: 10.1007/BF02151017. [DOI] [PubMed] [Google Scholar]
  7. Marzi A., de Toranzo E. G., Castro J. A. Studies on the prevention of CCl4 induced liver necrosis by agents having effects on cell membrane. Res Commun Chem Pathol Pharmacol. 1980 Dec;30(3):581–584. [PubMed] [Google Scholar]
  8. RECKNAGEL R. O., LITTERIA M. Biochemical changes in carbon tetrachloride fatty liver: concentration of carbon tetrachloride in liver and blood. Am J Pathol. 1960 May;36:521–531. [PMC free article] [PubMed] [Google Scholar]
  9. Rao K. S., Recknagel R. O. Early incorporation of carbon-labeled carbon tetrachloride into rat liver particulate lipids and proteins. Exp Mol Pathol. 1969 Apr;10(2):219–228. doi: 10.1016/0014-4800(69)90041-0. [DOI] [PubMed] [Google Scholar]
  10. Recknagel R. O. Carbon tetrachloride hepatotoxicity. Pharmacol Rev. 1967 Jun;19(2):145–208. [PubMed] [Google Scholar]
  11. STERKEL R. L., SPENCER J. A., WOLFSON S. K., Jr, WILLIAMS-ASHMAN H. G. Serum isocitric dehydrogenase activity with particular reference to liver disease. J Lab Clin Med. 1958 Aug;52(2):176–184. [PubMed] [Google Scholar]
  12. Villarruel M. C., Castro J. A. Reactions of trichloromethyl free radicals with aminoacids. Res Commun Chem Pathol Pharmacol. 1980 Apr;28(1):79–85. [PubMed] [Google Scholar]
  13. de Ferreyra E. C., de Fenos O. M., Bernacchi A. S., de Castro C. R., Castro J. A. Therapeutic effectiveness of cystamine and cysteine to reduce liver cell necrosis induced by several hepatotoxins. Toxicol Appl Pharmacol. 1979 Apr;48(2):221–228. doi: 10.1016/0041-008x(79)90027-9. [DOI] [PubMed] [Google Scholar]
  14. de Toranzo E. G., Marzi A., Castro J. A. Effects of cysteine and cystamine on the carbon tetrachloride induced decrease in arachidonic acid content of rat liver microsomal phospholipids. Toxicology. 1981;19(1):77–82. doi: 10.1016/0300-483x(81)90067-6. [DOI] [PubMed] [Google Scholar]

Articles from British journal of experimental pathology are provided here courtesy of Wiley

RESOURCES